{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:45:46Z","timestamp":1792784746543,"version":"4.5.0"},"reference-count":154,"publisher":"American Chemical Society (ACS)","issue":"40","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["02063263133"],"award-info":[{"award-number":["02063263133"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2025KJ067"],"award-info":[{"award-number":["2025KJ067"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Tianjin City","award":["24JCYBJC01790"],"award-info":[{"award-number":["24JCYBJC01790"]}]},{"name":"Haihe Laboratory of Sustainable Chemical Transformations","award":["YYJC202102"],"award-info":[{"award-number":["YYJC202102"]}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["52293383"],"award-info":[{"award-number":["52293383"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["52373153"],"award-info":[{"award-number":["52373153"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation Youth Cultivation Project of Tianjin Medical University Cancer Institute and Hospital","award":["QN2516"],"award-info":[{"award-number":["QN2516"]}],"id":[{"id":"https:\/\/ror.org\/0152hn881","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mutations or overexpression of proteins contribute to the pathogenesis and progression of numerous diseases, including cancers and neurodegenerative disorders. Traditional small-molecule inhibitors have played a crucial role in treating these diseases; however, they still face several limitations, such as off-target toxicity due to high required concentrations and the inability to inhibit undruggable proteins. Targeted protein degradation (TPD) technology, which operates via a catalytic degradation mechanism, has partially addressed these challenges. Nevertheless, its relatively large molecular weight often leads to issues such as poor solubility and low bioavailability, significantly hindering in vivo application. Nanotechnology offers a promising platform to overcome these obstacles. It can not only serve as a delivery system to transport TPD molecules to disease sites in response to various signals, thereby enhancing targeting specificity, but can also possess inherent TPD functionality. Through flexible structural design, nanotechnology enables the investigation of various factors influencing degradation efficiency, thereby providing theoretical guidance for developing more effective TPD strategies. This work highlights that nanotechnology, as a flexibly and precisely tunable multifunctional platform, facilitates the exploration of core mechanisms that dominate the protein degradation efficiency of TPD technology. The summarized research rules provide rational guidance for the design of high-efficiency TPD systems. Furthermore, this review systematically discusses the existing bottlenecks of current nano-TPD strategies, aiming to advance the construction of high-performance nano-TPD platforms and accelerate their clinical translation.<\/jats:p>","DOI":"10.1021\/acsami.6c12624","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:01:18Z","timestamp":1791244878000},"page":"54313-54340","source":"Crossref","is-referenced-by-count":0,"title":["Recent Advances in Nanotechnology for Targeted Protein Degradation"],"prefix":"10.1021","volume":"18","author":[{"given":"Mengchen","family":"Xu","sequence":"first","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, P.R. China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, P.R. China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Chen","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, P.R. China, 300071"]},{"name":"Tianjin Third Central Hospital affiliated to Nankai University , , ,","place":["Tianjin, China, 300170"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, P.R. China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Tianjin\u2019s Clinical Research Center for Cancer , , ,","place":["Tianjin, P.R. China, 300060"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8511-3922","authenticated-orcid":true,"given":"Feihe","family":"Ma","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, P.R. China, 300071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9534-795X","authenticated-orcid":true,"given":"Linqi","family":"Shi","sequence":"additional","affiliation":[{"name":"Nankai University , , ,","place":["Tianjin, P.R. China, 300071"]},{"name":"Tianjin\u2019s Clinical Research Center for Cancer , , ,","place":["Tianjin, P.R. China, 300060"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"2026101404070008700_cit1","doi-asserted-by":"publisher","first-page":"11454","DOI":"10.1021\/acs.jmedchem.2c00844","article-title":"Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy","volume":"65","author":"Fang","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit2","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1021\/acs.jmedchem.2c01712","article-title":"Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit3","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202507702","article-title":"Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy","volume":"64","author":"Zhang","year":"2025","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026101404070008700_cit4","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188503","article-title":"A deep proteome and transcriptome abundance atlas of 29 healthy human tissues","volume":"15","author":"Wang","year":"2019","journal-title":"Mol. Syst. Biol."},{"key":"2026101404070008700_cit5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S0140-6736(20)30164-1","article-title":"Small molecules, big impact: 20 years of targeted therapy in oncology","volume":"395","author":"Bedard","year":"2020","journal-title":"The Lancet"},{"key":"2026101404070008700_cit6","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/acs.jmedchem.0c01511","article-title":"Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases","volume":"64","author":"Xie","year":"2021","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit7","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1021\/acs.jmedchem.9b01317","article-title":"Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives","volume":"63","author":"Zhuang","year":"2019","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.chembiol.2021.03.005","article-title":"The role of reversible and irreversible covalent chemistry in targeted protein degradation","volume":"28","author":"Kiely-Collins","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"2026101404070008700_cit9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduction Targeted Ther."},{"key":"2026101404070008700_cit10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ebiom.2018.09.005","article-title":"Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs","volume":"36","author":"An","year":"2018","journal-title":"EBioMedicine"},{"key":"2026101404070008700_cit11","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/anie.201507978","article-title":"Small-Molecule PROTACS: New Approaches to Protein Degradation","volume":"55","author":"Toure","year":"2016","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026101404070008700_cit12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-pharmtox-010715-103440","article-title":"Drugging Undruggable Molecular Cancer Targets","volume":"56","author":"Lazo","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2026101404070008700_cit13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduction Targeted Ther."},{"key":"2026101404070008700_cit14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: an emerging drug discovery paradigm","volume":"16","author":"Lai","year":"2016","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026101404070008700_cit15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026101404070008700_cit16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"2026101404070008700_cit17","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf6249","article-title":"Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras","volume":"382","author":"Ahn","year":"2023","journal-title":"Science"},{"key":"2026101404070008700_cit18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","article-title":"Allele-selective lowering of mutant HTT protein by HTT\u2013LC3 linker compounds","volume":"575","author":"Li","year":"2019","journal-title":"Nature"},{"key":"2026101404070008700_cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.medp.2023.100004","article-title":"Perspectives of autophagy-tethering compounds (ATTECs) in drug discovery","volume":"1","author":"Ding","year":"2024","journal-title":"Med. Plus"},{"key":"2026101404070008700_cit20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-024-07089-6","article-title":"Targeted protein degradation via intramolecular bivalent glues","volume":"627","author":"Hsia","year":"2024","journal-title":"Nature"},{"key":"2026101404070008700_cit21","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1039\/D2CS00197G","article-title":"Chasing molecular glue degraders: screening approaches","volume":"51","author":"Domostegui","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"2026101404070008700_cit22","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1016\/j.scib.2023.10.021","article-title":"Targeted clearance of mitochondria by an autophagy-tethering compound (ATTEC) and its potential therapeutic effects","volume":"68","author":"Tan","year":"2023","journal-title":"Sci. Bull."},{"key":"2026101404070008700_cit23","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s41422-021-00532-7","article-title":"Degradation of lipid droplets by chimeric autophagy-tethering compounds","volume":"31","author":"Fu","year":"2021","journal-title":"Cell Res."},{"key":"2026101404070008700_cit24","doi-asserted-by":"publisher","first-page":"9243","DOI":"10.1039\/D2CS00362G","article-title":"Applications of covalent chemistry in targeted protein degradation","volume":"51","author":"Lu","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"2026101404070008700_cit25","doi-asserted-by":"publisher","first-page":"8798","DOI":"10.1021\/acs.jmedchem.2c00728","article-title":"Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein Degradation","volume":"65","author":"Yan","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit26","doi-asserted-by":"publisher","first-page":"8832","DOI":"10.1039\/d2cs00624c","article-title":"Emerging degrader technologies engaging lysosomal pathways","volume":"51","author":"Ding","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"2026101404070008700_cit27","doi-asserted-by":"publisher","first-page":"24785","DOI":"10.1021\/jacs.3c08843","article-title":"ATNC: Versatile Nanobody Chimeras for Autophagic Degradation of Intracellular Unligandable and Undruggable Proteins","volume":"145","author":"He","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit28","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1021\/acschembio.5b00442","article-title":"HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins","volume":"10","author":"Buckley","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"2026101404070008700_cit29","doi-asserted-by":"publisher","first-page":"7619","DOI":"10.1021\/acs.jmedchem.1c02001","article-title":"Ispinesib as an Effective Warhead for the Design of Autophagosome-Tethering Chimeras: Discovery of Potent Degraders of Nicotinamide Phosphoribosyltransferase (NAMPT)","volume":"65","author":"Dong","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit30","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.1021\/acs.jmedchem.3c00828","article-title":"Degradation of Cyclin-Dependent Kinase 9\/Cyclin T1 by Optimized Microtubule-Associated Protein 1 Light Chain 3 Beta-Recruiting Coumarin Analogs","volume":"66","author":"Zeng","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit31","doi-asserted-by":"publisher","first-page":"13487","DOI":"10.1021\/acs.jmedchem.1c00900","article-title":"Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer","volume":"64","author":"Xiang","year":"2021","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit32","doi-asserted-by":"publisher","first-page":"40751","DOI":"10.1021\/jacs.5c13695","article-title":"Development of Dual-Receptor Lysosome-Targeting Chimeras for Protein Degradation","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit33","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1039\/D1CS00762A","article-title":"Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation","volume":"51","author":"Chen","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"2026101404070008700_cit34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pharmthera.2017.02.027","article-title":"Targeted protein degradation by PROTACs","volume":"174","author":"Neklesa","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"2026101404070008700_cit35","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.celrep.2014.08.025","article-title":"Inducible In Vivo Silencing of Brd4 Identifies Potential Toxicities of Sustained BET Protein Inhibition","volume":"8","author":"Bolden","year":"2014","journal-title":"Cell Rep."},{"key":"2026101404070008700_cit36","doi-asserted-by":"publisher","first-page":"8822","DOI":"10.1021\/acs.jmedchem.3c00405","article-title":"Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer","volume":"66","author":"Han","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit37","doi-asserted-by":"publisher","first-page":"11158","DOI":"10.1021\/acs.jmedchem.3c00585","article-title":"Discovery of BWA-522, a First-in-Class and Orally Bioavailable PROTAC Degrader of the Androgen Receptor Targeting N-Terminal Domain for the Treatment of Prostate Cancer","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit38","doi-asserted-by":"publisher","first-page":"8143","DOI":"10.1021\/acs.jmedchem.4c02682","article-title":"Discovery of Novel SHP2 ATTEC Degraders against Pancreatic Ductal Adenocarcinoma Harboring KRAS(G12D) Mutations","volume":"68","author":"Zhong","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit39","doi-asserted-by":"publisher","first-page":"10204","DOI":"10.1038\/s41467-024-54409-5","article-title":"Critical assessment of LC3\/GABARAP ligands used for degrader development and ligandability of LC3\/GABARAP binding pockets","volume":"15","author":"Schwalm","year":"2024","journal-title":"Nat. Commun."},{"key":"2026101404070008700_cit40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1039\/D2MH01358D","article-title":"Polymeric nanoparticle-based nanovaccines for cancer immunotherapy","volume":"10","author":"Zhang","year":"2023","journal-title":"Mater. Horiz."},{"key":"2026101404070008700_cit41","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202309927","article-title":"Controlled Refolding of Denatured IL-12 Using In Situ Antigen-Capturing Nanochaperone Remarkably Reduces the Systemic Toxicity and Enhances Cancer Immunotherapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"2026101404070008700_cit42","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202200192","article-title":"Tailoring a Nanochaperone to Regulate \u03b1-Synuclein Assembly","volume":"61","author":"Wu","year":"2022","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026101404070008700_cit43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121841","article-title":"Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity","volume":"290","author":"Yang","year":"2022","journal-title":"Biomaterials"},{"key":"2026101404070008700_cit44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.142374","article-title":"Allosteric synthetic antibody (Allo-SyAb) for improved cancer immunotherapy","volume":"463","author":"Chen","year":"2023","journal-title":"Chem. Eng. J."},{"key":"2026101404070008700_cit45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bioactmat.2025.06.010","article-title":"Synergistic therapy for pancreatic cancer by deactivating cancer-associated fibroblasts and driving T-cell migration into tumor microenvironment using nanochaperone delivery system","volume":"52","author":"Chen","year":"2025","journal-title":"Bioact. Mater."},{"key":"2026101404070008700_cit46","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10118-024-3090-z","article-title":"A Dynamic Covalent Bonding-based Nanoplatform for Intracellular Co-Delivery of Protein Drugs and Chemotherapeutics with Enhanced Anti-Cancer Effect","volume":"42","author":"Liu","year":"2024","journal-title":"Chinese J. Polym. Sci."},{"key":"2026101404070008700_cit47","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1007\/s10118-026-3567-z","article-title":"Bioactive Nanomaterials for Cancer Immunotherapy","volume":"44","author":"Zhang","year":"2026","journal-title":"Chinese J. Polym. Sci."},{"key":"2026101404070008700_cit48","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41467-023-44665-2","article-title":"In vivo assembly enhanced binding effect augments tumor specific ferroptosis therapy","volume":"15","author":"Hou","year":"2024","journal-title":"Nat. Commun."},{"key":"2026101404070008700_cit49","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s10118-025-3429-0","article-title":"Antioxidant Glycopolypeptide Micelles for Targeted Delivery of Silibinin to Hepatocellular Carcinoma Cells","volume":"43","author":"Chen","year":"2025","journal-title":"Chinese J. Polym. Sci."},{"key":"2026101404070008700_cit50","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1007\/s10118-024-3169-6","article-title":"Nanochaperones Based on Hydrophobic Interaction and Coordination Inhibit Protein Misfolding and Fibrillation","volume":"42","author":"Wang","year":"2024","journal-title":"Chinese J. Polym. Sci."},{"key":"2026101404070008700_cit51","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13045-021-01146-7","article-title":"Protein degradation technology: a strategic paradigm shift in drug discovery","volume":"14","author":"Li","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"2026101404070008700_cit52","doi-asserted-by":"publisher","DOI":"10.1126\/science.adx5094","article-title":"Targeted protein degradation in the transmembrane and extracellular space","volume":"390","author":"Zhu","year":"2025","journal-title":"Science"},{"key":"2026101404070008700_cit53","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1039\/D2CS00220E","article-title":"Chemistries of bifunctional PROTAC degraders","volume":"51","author":"Cao","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"2026101404070008700_cit54","doi-asserted-by":"publisher","first-page":"21344","DOI":"10.1021\/acs.jmedchem.4c02273","article-title":"Development of Novel Silicon-Based Hydrophobic Tags (SiHyT) for Targeted Proteins Degradation","volume":"67","author":"Ma","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit55","doi-asserted-by":"publisher","DOI":"10.1063\/5.0255745","article-title":"Recent advances and clinical prospects of non-viral brain-targeted gene delivery systems","volume":"12","author":"Wang","year":"2025","journal-title":"Appl. Phys. Rev."},{"key":"2026101404070008700_cit56","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1021\/acs.jmedchem.0c01689","article-title":"Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery","volume":"64","author":"Pei","year":"2021","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit57","doi-asserted-by":"publisher","first-page":"7008","DOI":"10.1021\/jacs.5c17801","article-title":"An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy","volume":"148","author":"Xiao","year":"2026","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41586-022-05235-6","article-title":"Antibody targeting of E3 ubiquitin ligases for receptor degradation","volume":"610","author":"Marei","year":"2022","journal-title":"Nature"},{"key":"2026101404070008700_cit59","doi-asserted-by":"publisher","first-page":"25708","DOI":"10.1021\/acs.jmedchem.5c02379","article-title":"Advances in Peptide-Based Chimeric Strategies for Targeted Protein Degradation","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-023-00630-7","article-title":"Targeted degradation of \u03b1-synuclein aggregates in Parkinson\u2019s disease using the AUTOTAC technology","volume":"18","author":"Lee","year":"2023","journal-title":"Mol. Neurodegeneration"},{"key":"2026101404070008700_cit61","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41467-022-28520-4","article-title":"The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system","volume":"13","author":"Ji","year":"2022","journal-title":"Nat. Commun."},{"key":"2026101404070008700_cit62","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","article-title":"AUTACs: Cargo-Specific Degraders Using Selective Autophagy","volume":"76","author":"Takahashi","year":"2019","journal-title":"Mol. Cell"},{"key":"2026101404070008700_cit63","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1021\/acs.jmedchem.4c01017","article-title":"Structural and Physicochemical Features of Oral PROTACs","volume":"67","author":"Schade","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit64","doi-asserted-by":"publisher","first-page":"13029","DOI":"10.1021\/acs.jmedchem.2c00877","article-title":"Linker-Dependent Folding Rationalizes PROTAC Cell Permeability","volume":"65","author":"Poongavanam","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit65","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nchembio.2329","article-title":"Structural basis of PROTAC cooperative recognition for selective protein degradation","volume":"13","author":"Gadd","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"2026101404070008700_cit66","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.chembiol.2023.01.007","article-title":"Ternary complex dissociation kinetics contribute to mutant-selective EGFR degradation","volume":"30","author":"Rosenberg","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"2026101404070008700_cit67","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.chembiol.2023.06.002","article-title":"Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization","volume":"30","author":"Schwalm","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"2026101404070008700_cit68","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41589-019-0294-6","article-title":"BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design","volume":"15","author":"Farnaby","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"2026101404070008700_cit69","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acschembio.9b00092","article-title":"SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate","volume":"14","author":"Roy","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"2026101404070008700_cit70","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41589-020-00686-2","article-title":"Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes","volume":"17","author":"Schiemer","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"2026101404070008700_cit71","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.chembiol.2017.09.010","article-title":"Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead","volume":"25","author":"Bondeson","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"2026101404070008700_cit72","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.101127","article-title":"PROTAC-induced protein structural dynamics in targeted protein degradation","volume":"13","author":"Hung","year":"2025","journal-title":"eLife"},{"key":"2026101404070008700_cit73","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41467-018-08027-7","article-title":"Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase","volume":"10","author":"Smith","year":"2019","journal-title":"Nat. Commun."},{"key":"2026101404070008700_cit74","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1021\/acschembio.8b01094","article-title":"PROTAC-Mediated Degradation of Bruton\u2019s Tyrosine Kinase Is Inhibited by Covalent Binding","volume":"14","author":"Tinworth","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"2026101404070008700_cit75","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.1021\/jacs.2c12824","article-title":"Targeted Biomolecule Regulation Platform: A Split-and-Mix PROTAC Approach","volume":"145","author":"Yang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12943-022-01535-7","article-title":"Clinical considerations for the design of PROTACs in cancer","volume":"21","author":"Nieto-Jim\u00e9nez","year":"2022","journal-title":"Mol. Cancer"},{"key":"2026101404070008700_cit77","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026336","article-title":"The Role of MDM2 Amplification and Overexpression in Tumorigenesis","volume":"6","author":"Oliner","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2026101404070008700_cit78","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108532","article-title":"Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins","volume":"34","author":"Shirasaki","year":"2021","journal-title":"Cell Rep."},{"key":"2026101404070008700_cit79","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.chembiol.2021.04.007","article-title":"Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation","volume":"28","author":"Kannt","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"2026101404070008700_cit80","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202308049","article-title":"Nano Proteolysis Targeting Chimeras (PROTACs) with Anti-Hook Effect for Tumor Therapy","volume":"62","author":"Zhang","year":"2023","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026101404070008700_cit81","doi-asserted-by":"publisher","first-page":"10753","DOI":"10.1021\/jacs.4c00826","article-title":"Sulfatase-Induced In Situ Formulation of Antineoplastic Supra-PROTACs","volume":"146","author":"Chen","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit82","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202218128","article-title":"Targeted Degradation of PD-L1 and Activation of the STING Pathway by Carbon-Dot-Based PROTACs for Cancer Immunotherapy","volume":"62","author":"Su","year":"2023","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026101404070008700_cit83","doi-asserted-by":"publisher","first-page":"21860","DOI":"10.1021\/jacs.3c05948","article-title":"Selective Protein of Interest Degradation through the Split-and-Mix Liposome Proteolysis Targeting Chimera Approach","volume":"145","author":"Song","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit84","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1021\/jacs.4c16438","article-title":"DNA Tetrahedron-Driven Multivalent Proteolysis-Targeting Chimeras: Enhancing Protein Degradation Efficiency and Tumor Targeting","volume":"147","author":"Li","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit85","doi-asserted-by":"publisher","first-page":"24506","DOI":"10.1021\/jacs.3c03899","article-title":"Covalent LYTAC Enabled by DNA Aptamers for Immune Checkpoint Degradation Therapy","volume":"145","author":"Li","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit86","doi-asserted-by":"publisher","first-page":"16377","DOI":"10.1021\/jacs.1c08521","article-title":"Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation","volume":"143","author":"Zhang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit87","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202203309","article-title":"Semiconducting Polymer Nanoparticles with Surface-Mimicking Protein Secondary Structure as Lysosome-Targeting Chimaeras for Self-Synergistic Cancer Immunotherapy","volume":"34","author":"Qi","year":"2022","journal-title":"Adv. Mater."},{"key":"2026101404070008700_cit88","doi-asserted-by":"publisher","first-page":"20989","DOI":"10.1021\/jacs.5c05456","article-title":"Phototriggered LYTAC: Photoactive Bispecific Aptamer Chimera Enhances Targeted Degradation of Membrane Protein through Regulating Cell Autophagy","volume":"147","author":"Zhang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit89","doi-asserted-by":"publisher","first-page":"12614","DOI":"10.1021\/acs.jmedchem.3c01303","article-title":"Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides","volume":"66","author":"Tong","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit90","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1021\/acsmacrolett.4c00789","article-title":"Autophagy-Activating Nanoautophagosome-Tethering Compounds for Targeted Protein Degradation Specifically in Tumor Cells","volume":"14","author":"Xu","year":"2025","journal-title":"ACS Macro Lett."},{"key":"2026101404070008700_cit91","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41586-024-07947-3","article-title":"Transferrin receptor targeting chimeras for membrane protein degradation","volume":"638","author":"Zhang","year":"2024","journal-title":"Nature"},{"key":"2026101404070008700_cit92","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41589-021-00770-1","article-title":"LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation","volume":"17","author":"Ahn","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"2026101404070008700_cit93","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41586-024-07948-2","article-title":"Designed endocytosis-inducing proteins degrade targets and amplify signals","volume":"638","author":"Huang","year":"2024","journal-title":"Nature"},{"key":"2026101404070008700_cit94","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/s41589-025-01924-1","article-title":"Polyvalent folate receptor-targeting chimeras for degradation of membrane proteins","volume":"21","author":"Xiao","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"2026101404070008700_cit95","doi-asserted-by":"publisher","first-page":"25490","DOI":"10.1021\/jacs.4c04794","article-title":"Development of Integrin-Facilitated Bispecific Aptamer Chimeras for Membrane Protein Degradation","volume":"146","author":"Sun","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit96","doi-asserted-by":"publisher","first-page":"17728","DOI":"10.1021\/jacs.4c02463","article-title":"Lysosome Targeting Chimaeras for Glut1-Facilitated Targeted Protein Degradation","volume":"146","author":"Luo","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit97","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1039\/D2CS00200K","article-title":"Target and tissue selectivity of PROTAC degraders","volume":"51","author":"Guenette","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"2026101404070008700_cit98","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","article-title":"Advancing targeted protein degradation for cancer therapy","volume":"21","author":"Dale","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"2026101404070008700_cit99","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","article-title":"Targeted protein degradation: expanding the toolbox","volume":"18","author":"Schapira","year":"2019","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026101404070008700_cit100","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1021\/acs.jmedchem.2c01648","article-title":"Targeted Protein Degradation Induced by HEMTACs Based on HSP90","volume":"66","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit101","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41565-024-01801-3","article-title":"Targeted protein degradation via cellular trafficking of nanoparticles","volume":"20","author":"Liu","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"2026101404070008700_cit102","doi-asserted-by":"publisher","first-page":"19107","DOI":"10.1021\/jacs.3c07687","article-title":"Harnessing the Lysosomal Sorting Signals of the Cation-Independent Mannose-6-Phosphate Receptor for Targeted Degradation of Membrane Proteins","volume":"145","author":"Yu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit103","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202411061","article-title":"Lysosome-Targeting Protein Degradation Through Endocytosis Pathway Triggered by Polyvalent Nano-Chimera for AD Therapy","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"key":"2026101404070008700_cit104","doi-asserted-by":"publisher","first-page":"29609","DOI":"10.1021\/jacs.4c10010","article-title":"Intelligent Modular DNA Lysosome-Targeting Chimera Nanodevice for Precision Tumor Therapy","volume":"146","author":"Cui","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit105","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202417942","article-title":"A Bifunctional Lysosome-Targeting Chimera Nanoplatform for Tumor-Selective Protein Degradation and Enhanced Cancer Immunotherapy","volume":"37","author":"Xing","year":"2025","journal-title":"Adv. Mater."},{"key":"2026101404070008700_cit106","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305364","article-title":"Nano-LYTACs for Degradation of Membrane Proteins and Inhibition of CD24\/Siglec-10 Signaling Pathway","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"key":"2026101404070008700_cit107","doi-asserted-by":"publisher","first-page":"34669","DOI":"10.1021\/jacs.4c13022","article-title":"Sonodynamic Nano-LYTACs Reverse Tumor Immunosuppressive Microenvironment for Cancer Immunotherapy","volume":"146","author":"Xu","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"2026101404070008700_cit108","doi-asserted-by":"publisher","first-page":"13417","DOI":"10.1021\/acsnano.6c04420","article-title":"Targeted Protein Degradation and Delivery Strategies in the Context of Neurological Disorders","volume":"20","author":"Lu","year":"2026","journal-title":"ACS Nano"},{"key":"2026101404070008700_cit109","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn8079","article-title":"Supramolecular artificial Nano-AUTACs enable tumor-specific metabolism protein degradation for synergistic immunotherapy","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"2026101404070008700_cit110","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1038\/s41467-022-32050-4","article-title":"Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy","volume":"13","author":"Gao","year":"2022","journal-title":"Nat. Commun."},{"key":"2026101404070008700_cit111","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202515006","article-title":"Engineering Metal-Organic-Framework-Based STING Nanoagonists for PROTAC-Enhanced Cancer Chemo-Metalloimmunotherapy","volume":"13","author":"Chen","year":"2026","journal-title":"Adv. Sci."},{"key":"2026101404070008700_cit112","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41392-024-01983-1","article-title":"Sequential responsive nano-PROTACs for precise intracellular delivery and enhanced degradation efficacy in colorectal cancer therapy","volume":"9","author":"Yang","year":"2024","journal-title":"Signal Transduction Targeted Ther."},{"key":"2026101404070008700_cit113","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202314203","article-title":"Synergizing CXCL9 with BRD4-PROTAC Using Nanochaperone Boosts Robust T Cell-Dependent Antitumor Immune Responses for Cancer Immunotherapy","volume":"34","author":"Chen","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"2026101404070008700_cit114","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202500311","article-title":"A Self-Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple-Negative Breast Cancer Therapy","volume":"12","author":"Lin","year":"2025","journal-title":"Adv. Sci."},{"key":"2026101404070008700_cit115","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1007\/s12274-024-6974-x","article-title":"A self-assembled affibody-PROTAC conjugate nanomedicine for targeted cancer therapy","volume":"17","author":"Li","year":"2024","journal-title":"Nano Res."},{"key":"2026101404070008700_cit116","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202504253","article-title":"Biomimetic Hybrid PROTAC Nanovesicles Block Multiple DNA Repair Pathways to Overcome Temozolomide Resistance Against Orthotopic Glioblastoma","volume":"37","author":"Xu","year":"2025","journal-title":"Adv. Mater."},{"key":"2026101404070008700_cit117","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.chembiol.2024.01.002","article-title":"Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor","volume":"31","author":"Su","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"2026101404070008700_cit118","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202208553","article-title":"Checkpoint Nano-PROTACs for Activatable Cancer Photo-Immunotherapy","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"key":"2026101404070008700_cit119","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50735-w","article-title":"A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy","volume":"15","author":"Gao","year":"2024","journal-title":"Nat. Commun."},{"key":"2026101404070008700_cit120","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202405475","article-title":"Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy","volume":"36","author":"Choi","year":"2024","journal-title":"Adv. Mater."},{"key":"2026101404070008700_cit121","doi-asserted-by":"publisher","first-page":"10458","DOI":"10.1021\/acs.jmedchem.3c00587","article-title":"Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy","volume":"66","author":"He","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026101404070008700_cit122","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202314132","article-title":"PROTAC Prodrug-Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"2026101404070008700_cit123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60039-2","article-title":"DNA nanoflower Oligo-PROTAC for targeted degradation of FUS to treat neurodegenerative diseases","volume":"16","author":"Ge","year":"2025","journal-title":"Nat. Commun."},{"key":"2026101404070008700_cit124","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202421713","article-title":"In Vivo Self-Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy","volume":"64","author":"Xie","year":"2025","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026101404070008700_cit125","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1039\/d5nr04462f","article-title":"Factors governing tumor penetration of nanomedicines: intrinsic and extrinsic determinants","volume":"18","author":"Shin","year":"2026","journal-title":"Nanoscale"},{"key":"2026101404070008700_cit126","doi-asserted-by":"publisher","first-page":"37383","DOI":"10.1021\/acsami.5c07366","article-title":"The Nanocarrier Landscape\u2014Evaluating Key Drug Delivery Vehicles and Their Capabilities: A Translational Perspective","volume":"17","author":"Khalid-Salako","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026101404070008700_cit127","doi-asserted-by":"publisher","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"2026101404070008700_cit128","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123621","article-title":"Proteolysis-targeting chimera (PROTAC) nanomedicines toward cancer treatment: From synthesis to therapeutic delivery","volume":"325","author":"Liu","year":"2026","journal-title":"Biomaterials"},{"key":"2026101404070008700_cit129","doi-asserted-by":"publisher","first-page":"28502","DOI":"10.1021\/acsnano.4c09800","article-title":"Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment","volume":"18","author":"Wu","year":"2024","journal-title":"ACS Nano"},{"key":"2026101404070008700_cit130","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2014.03.026","article-title":"PEG\u2013PLGA copolymers: Their structure and structure-influenced drug delivery applications","volume":"183","author":"Zhang","year":"2014","journal-title":"J. Controlled Release"},{"key":"2026101404070008700_cit131","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3390\/pharmaceutics17040501","article-title":"PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation","volume":"17","author":"Syahputra","year":"2025","journal-title":"Pharmaceutics"},{"key":"2026101404070008700_cit132","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00253-020-11073-1","article-title":"Current status on the biodegradability of acrylic polymers: microorganisms, enzymes and metabolic pathways involved","volume":"105","author":"Gayt\u00e1n","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"2026101404070008700_cit133","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1039\/c3cs35405a","article-title":"Synthesis of mesoporous silica nanoparticles","volume":"42","author":"Wu","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"2026101404070008700_cit134","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.2147\/IJN.S451919","article-title":"Strategies to Regulate the Degradation and Clearance of Mesoporous Silica Nanoparticles: A Review","volume":"19","author":"Zhang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"2026101404070008700_cit135","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.144400","article-title":"Mitigating metal-organic framework (MOF) toxicity for biomedical applications","volume":"471","author":"Wi\u015bniewska","year":"2023","journal-title":"Chem. Eng. J."},{"key":"2026101404070008700_cit136","doi-asserted-by":"publisher","first-page":"15606","DOI":"10.1021\/acs.jpcc.1c03876","article-title":"Guest Leakage from ZIF-8 Particles under Drug Delivery Conditions: Quantitative Characterization and Guest-Induced Framework Stabilization","volume":"125","author":"Poryvaev","year":"2021","journal-title":"J. Phys. Chem. C"},{"key":"2026101404070008700_cit137","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","article-title":"Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation","volume":"244","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"2026101404070008700_cit138","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1039\/c1cs15233e","article-title":"Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment","volume":"41","author":"Walkey","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"2026101404070008700_cit139","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz0868","article-title":"Physical traits of cancer","volume":"370","author":"Nia","year":"2020","journal-title":"Science"},{"key":"2026101404070008700_cit140","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1073\/pnas.1522080113","article-title":"Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026101404070008700_cit141","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/pharmaceutics12040371","article-title":"Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell","volume":"12","author":"Manzanares","year":"2020","journal-title":"Pharmaceutics"},{"key":"2026101404070008700_cit142","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S36111","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","author":"Fr\u00f6hlich","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"2026101404070008700_cit143","doi-asserted-by":"publisher","first-page":"11773","DOI":"10.1021\/acsnano.7b08008","article-title":"A Decade of the Protein Corona","volume":"11","author":"Ke","year":"2017","journal-title":"ACS Nano"},{"key":"2026101404070008700_cit144","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jconrel.2012.11.016","article-title":"Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon","volume":"165","author":"Shiraishi","year":"2013","journal-title":"J. Control. Release"},{"key":"2026101404070008700_cit145","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2026.115876","article-title":"Engineering brain-penetrant PROTACs: Bridging molecular design and CNS delivery","volume":"234","author":"Li","year":"2026","journal-title":"Adv. Drug Delivery Rev."},{"key":"2026101404070008700_cit146","doi-asserted-by":"publisher","first-page":"37435","DOI":"10.1021\/acsami.5c02939","article-title":"Self-Assembled Molecular Glue Prodrug System for Enhanced Synergistic Tumor Therapy by Combining CDK12 Protein Degradation and Immunotherapy","volume":"17","author":"Zhang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026101404070008700_cit147","doi-asserted-by":"publisher","first-page":"67595","DOI":"10.1021\/acsami.5c18202","article-title":"Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer Treatment","volume":"17","author":"Zhao","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026101404070008700_cit148","doi-asserted-by":"publisher","first-page":"10382","DOI":"10.1038\/s41467-024-54854-2","article-title":"MMP-2-triggered, mitochondria-targeted PROTAC-PDT therapy of breast cancer and brain metastases inhibition","volume":"15","author":"Tong","year":"2024","journal-title":"Nat. Commun."},{"key":"2026101404070008700_cit149","doi-asserted-by":"publisher","first-page":"15344","DOI":"10.1073\/pnas.1411499111","article-title":"Investigating the optimal size of anticancer nanomedicine","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026101404070008700_cit150","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1021\/acs.biomac.7b00068","article-title":"Enhancing Tumor Penetration of Nanomedicines","volume":"18","author":"Sun","year":"2017","journal-title":"Biomacromolecules"},{"key":"2026101404070008700_cit151","doi-asserted-by":"publisher","first-page":"18619","DOI":"10.1021\/acsami.7b05383","article-title":"Size-Dependent Regulation of Intracellular Trafficking of Polystyrene Nanoparticle-Based Drug-Delivery Systems","volume":"9","author":"Wang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026101404070008700_cit152","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1021\/acsmacrolett.0c00488","article-title":"100th Anniversary of Macromolecular Science Viewpoint: Biological Stimuli-Sensitive Polymer Prodrugs and Nanoparticles for Tumor-Specific Drug Delivery","volume":"9","author":"Sun","year":"2020","journal-title":"ACS Macro Lett."},{"key":"2026101404070008700_cit153","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jconrel.2020.03.022","article-title":"Evasion of the accelerated blood clearance phenomenon by polysarcosine coating of liposomes","volume":"322","author":"Son","year":"2020","journal-title":"J. Control. Release"},{"key":"2026101404070008700_cit154","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jconrel.2021.04.001","article-title":"Unmasking CSF protein corona: Effect on targeting capacity of nanoparticles","volume":"333","author":"Wang","year":"2021","journal-title":"J. Control. Release"}],"container-title":["ACS Applied Materials &amp; Interfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsami.6c12624","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aamick\/article-pdf\/doi\/10.1021\/acsami.6c12624\/68750853\/am-2026-12624e.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aamick\/article-pdf\/doi\/10.1021\/acsami.6c12624\/68750853\/am-2026-12624e.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:29:18Z","timestamp":1791966558000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aamick\/article\/18\/40\/54313\/5444859\/Recent-Advances-in-Nanotechnology-for-Targeted"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":154,"journal-issue":{"issue":"40","published-online":{"date-parts":[[2026,10,5]]},"published-print":{"date-parts":[[2026,10,14]]}},"URL":"https:\/\/doi.org\/10.1021\/acsami.6c12624","relation":{},"ISSN":["1944-8244","1944-8252"],"issn-type":[{"value":"1944-8244","type":"print"},{"value":"1944-8252","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]}}}